In the News November 28, 2016

Bloomberg BNA | FDA Issues Guidance for Quality Contracts Between Drugmakers

Cathy Burgess comments on final guidance by the U.S. Food and Drug Administration for companies involved in contract drug manufacturing.
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.